HCW Biologics Inc. (HCWB)
0.35
0.01 (2.22%)
At close: Jan 15, 2025, 2:23 PM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Revenue | 2.84M | 6.72M | n/a | 4.10M | n/a |
| Cost of Revenue | 2.28M | 4.14M | 543.60K | n/a | 421.82K |
| Gross Profit | 560.36K | 2.59M | -543.60K | 4.10M | -421.82K |
| Operating Income | -25.72M | -15.08M | -13.37M | -5.82M | -7.37M |
| Interest Income | n/a | 126.66K | 505.37K | 22.32K | 72.35K |
| Pretax Income | -24.99M | -14.90M | -12.86M | -5.80M | -7.29M |
| Net Income | -24.99M | -14.72M | -12.36M | -5.78M | -7.22M |
| Selling & General & Admin | 13.08M | 8.33M | 4.98M | 2.44M | 1.80M |
| Research & Development | 7.68M | 9.34M | 8.17M | 7.26M | 5.39M |
| Other Expenses | 5.52M | 304.74K | 218.47K | 233.04K | 171.42K |
| Operating Expenses | 26.28M | 17.67M | 13.37M | 9.92M | 7.37M |
| Interest Expense | 283.04K | 126.66K | n/a | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 28.56M | 21.80M | 13.37M | 9.92M | 7.37M |
| Income Tax | n/a | -178.07K | -505.37K | -22.32K | -72.35K |
| Shares Outstanding (Basic) | 35.93M | 35.82M | 35.77M | 36.70M | 36.70M |
| Shares Outstanding (Diluted) | 35.93M | 35.82M | 35.77M | 36.70M | 36.70M |
| EPS (Basic) | -0.7 | -0.41 | -0.35 | -0.16 | -0.2 |
| EPS (Diluted) | -0.7 | -0.41 | -0.35 | -0.16 | -0.2 |
| EBITDA | -23.58M | -14.18M | -12.82M | -5.25M | -6.94M |
| Depreciation & Amortization | 1.14M | 589.61K | 543.60K | 572.87K | 421.82K |